← Browse by Condition
Medical Condition
metastatic hormone sensitive prostate cancer mhspc
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT03903835 Phase 3
Recruiting
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Enrollment
750 pts
Location
Belgium, Norway, Swe...
Sponsor
Karolinska Institutet
NCT06661122
Recruiting
A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
Enrollment
100 pts
Location
Japan
Sponsor
Bayer